Neuphoria Therapeutics
$4.41
7
+$0.29+7.04% Today
Statistics
Day High
4.46
Day Low
4.07
52W High
21.4
52W Low
3.65
Volume
62,914
Avg. Volume
49,195
Mkt Cap
0
P/E Ratio
-
Dividend Yield
-
Dividend
-
Upcoming
Earnings
3JunExpected
Expected EPS
-0.56
Actual EPS
N/A
People Also Follow
This list is based on the watchlists of people on Stock Events who follow NEUP. It's not an investment recommendation.
Competitors
This list is an analysis based on recent market events. It's not an investment recommendation.
About
Neuphoria Therapeutics, Inc. is a clinical-stage biotechnology company dedicated to developing therapies that address the complex needs of individuals affected by neuropsychiatric disorders. The company was founded on December 23, 2024 and is headquartered in Burlington, MA.
Show more...
CEO
Dr. Spyridon Papapetropoulos M.D., Ph.D.
Employees
8
Country
US
ISIN
US64136E1029
Listings
0 Comments
Share your thoughts
FAQ
What is Neuphoria Therapeutics stock price today?▼
The current price of NEUP is $4.41 USD — it has increased by +7.04% in the past 24 hours. Watch Neuphoria Therapeutics stock price performance more closely on the chart.
What is Neuphoria Therapeutics stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Neuphoria Therapeutics stocks are traded under the ticker NEUP.
Is Neuphoria Therapeutics stock price growing?▼
NEUP stock has risen by +5% compared to the previous week, the month change is a +3.52% rise, over the last year Neuphoria Therapeutics has showed a -23.97% decrease.
When is the next Neuphoria Therapeutics earnings date?▼
Neuphoria Therapeutics is going to release the next earnings report on June 03, 2026.
How many employees does Neuphoria Therapeutics have?▼
As of April 02, 2026, the company has 8 employees.
In which sector is Neuphoria Therapeutics located?▼
Neuphoria Therapeutics operates in the Health Care sector.
When did Neuphoria Therapeutics complete a stock split?▼
Neuphoria Therapeutics has not had any recent stock splits.
Where is Neuphoria Therapeutics headquartered?▼
Neuphoria Therapeutics is headquartered in Burlington, US.